Smartleaf Asset Management’s AbbVie ABBV Stock Holding History

Smartleaf Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.83M	Buy	36,739 +1,868	+5%	+$414K	0.28%	67
2025 Q4	$8.01M	Buy	34,871 +4,631	+15%	+$1.05M	0.3%	65
2025 Q3	$6.75M	Buy	30,240 +8,345	+38%	+$1.7M	0.42%	46
2025 Q2	$3.99M	Sell	21,895 -3,201	-13%	-$595K	0.35%	56
2025 Q1	$5.15M	Buy	25,096 +2,378	+10%	+$462K	0.5%	38
2024 Q4	$4M	Buy	22,718 +3,489	+18%	+$641K	0.41%	43
2024 Q3	$3.75M	Buy	19,229 +4,438	+30%	+$828K	0.45%	44
2024 Q2	$2.5M	Buy	14,791 +2,806	+23%	+$465K	0.41%	46
2024 Q1	$2.16M	Buy	11,985 +2,321	+24%	+$400K	0.42%	52
2023 Q4	$1.45M	Buy	+9,664	New	+$1.41M	0.39%	63

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Smartleaf Asset Management's ABBV Position: Q1 2026 in Review

Smartleaf Asset Management increased its AbbVie (ABBV) stake by 5.4% in Q1 2026, buying an estimated $414K and bringing the position to 36,739 shares worth $7.83M. The position accounts for 0.28% of the portfolio, ranked #67.

Smartleaf Asset Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $8.01M in Q4 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Smartleaf Asset Management held 36,739 shares of AbbVie worth $7.83M as of Q1 2026.
Smartleaf Asset Management bought 1,868 AbbVie shares in Q1 2026, an estimated $414K.
AbbVie made up 0.28% of Smartleaf Asset Management's portfolio in Q1 2026, its #67 holding.
Smartleaf Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Smartleaf Asset Management's AbbVie position peaked at $8.01M in Q4 2025.
4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.